Press Releases

Press Releases

August 13, 2019
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced the closing of its previously announced underwritten public offe
August 09, 2019
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced the pricing of its previously announced underwritten public offe
August 07, 2019
August 07, 2019 04:23 PM Eastern Daylight Time
$13.5M revenues, 57% Q2 YOY revenue growth and 520 bps of gross margin increase | August 06, 2019
BILLERICA, Mass.--(BUSINESS WIRE)--
Adds broad-based experience growing and scaling multi-billion-dollar international companies | July 26, 2019
Billerica, Mass.
Continued growth in 2019 marked by new HD-X product launch, acquisition of the leading neurofilament light (Nf-L) antibody supplier, new corporate headquarters and new ground-breaking neurodegenerative research proving the utility of digital biomarkers ac | July 11, 2019
BILLERICA, Mass.--(BUSINESS WIRE)--
June 26, 2019
Quanterix Announces Agreement to Acquire UmanDiagnostics, World’s Leading Neurofilament Light (Nf-L) Antibody Supplier